Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

ClinicalTrials.gov ID: NCT00088166

Public ClinicalTrials.gov record NCT00088166. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-Blind, Dexamethasone-Sparing Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Placebo for Control of Symptoms Associated With Peritumoral Brain Edema in Patients With Malignant Brain Tumor Who Require Chronic Administration of High-Dose Dexamethasone

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and efficacy of XERECEPT® to dexamethasone (Decadron) a common treatment for symptoms of brain swelling (edema). This study is specifically aimed at patients who require chronic high doses of dexamethasone to manage symptoms.

Study identification

NCT ID
NCT00088166
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
200 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Aug 13, 2014

2004 – 2008

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
UCSF Fresno Center for Clinical Studies Fresno California 93702 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92658 —
Stanford University Medical Center Palo Alto California 94305 —
UC Davis Medical Center, Division of Medical Oncology Sacramento California 95817 —
UC San Diego, Thornton Hospital San Diego California 92037 —
University of Colorado Cancer Center Aurora Colorado 80045 —
Colorado Neurological Institute Englewood Colorado 80113 —
Mayo Clinic Jacksonville Florida 32224 —
Cancer Institute of Orlando Orlando Florida 32804 —
Moffitt Cancer Center & Research Institute Tampa Florida 33612-9497 —
Winship Cancer Institute, Emory University Atlanta Georgia 30322 —
Northwestern University, Feinberg School of Medicine Chicago Illinois 60611 —
Evanston Northwestern Healthcare Evanston Illinois 60201 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Hermelin Brain Tumor Center, Henry Ford Hospital Detroit Michigan 48202 —
Neurology Group of Bergen County Ridgewood New Jersey 07450 —
Dent Neurologic Institute Amherst New York 14226 —
Memorial Sloan Kettering Cancer Center New York New York 10021 —
Weill Medical College of Cornell University New York New York 10021 —
University Hematology Oncology Care, LLC Cincinnati Ohio 43210 —
Good Samaritan Hospital Cincinnati Ohio 45220 —
The Ohio State University Columbus Ohio 43210 —
Oregon Clinic Portland Oregon 97210 —
Virginia Mason Clinic Seattle Washington 98111 —
University of Wisconsin Madison Wisconsin 53792 —
Medical College of Wisconsin Milwaukee Wisconsin 53226-3596 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00088166, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00088166 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →